Phosphodiesterase-5 inhibitors and migraine.
Evans
Randolph W
RW
Department of Neurology, Glostrup Hospital, DK-2600 Glostrup.
Kruuse
C
C
D007172:Erectile Dysfunction / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000139:chemically induced*; D020326:Migraine without Aura / Q000188:drug therapy*; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011687:Purines; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013450:Sulfones
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D017366:Serotonin Receptor Agonists; D013450:Sulfones; D000068677:Sildenafil Citrate